Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration.

PURPOSE To use optical coherence tomography (OCT) to quantify intraretinal cystoid spaces (ICSs) and the outer nuclear layer (ONL) in patients with neovascular age-related macular degeneration (AMD) and to investigate the correlation of these parameters with visual acuity. METHODS StratusOCT (Carl Zeiss Meditec, Inc., Dublin, CA) images were collected from 53 patients receiving their initial treatment with intravitreous ranibizumab. Images were analyzed with custom software (OCTOR) that allows accurate manual segmentation of OCT B-scans and provides thickness/volume measurements of ICS, ONL, neurosensory retina, pigment epithelial detachments (PEDs), subretinal fluid (SRF), and subretinal tissue (SRT). Univariate and multivariate analyses were used to correlate OCT parameters with best corrected Snellen visual acuity. Reproducibility was assessed with weighted kappa statistics and intraclass correlation coefficients. RESULTS A multivariate linear regression model with adjusted R(2) showed that ONL volume and SRT thickness significantly correlated with Snellen visual acuity (R(2) = 0.15, P = 0.002 and R(2) = 0.19, P = 0.001, respectively) with an overall model R(2) of 0.34. Adjustment of ONL volume for ICS did not improve correlation with visual acuity, and ICS volume did not independently correlate with visual acuity. Weighted kappa statistics showed excellent intergrader agreement for both ICS and ONL measurements. CONCLUSIONS The results suggest that an increased total volume of the ONL is associated with decreased visual acuity in neovascular AMD and that the total volume of ICS does not correlate with visual acuity. Although the correlations detected in this study are modest, quantitative subanalysis of OCT images may be of greater clinical relevance in the context of more advanced OCT technology.

[1]  Gerald Liew,et al.  Ranibizumab for neovascular age-related macular degeneration. , 2007, The New England journal of medicine.

[2]  Peter K Kaiser,et al.  Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. , 2007, Ophthalmology.

[3]  Ali Erginay,et al.  Characterization of macular edema from various etiologies by optical coherence tomography. , 2005, American journal of ophthalmology.

[4]  H. Ozdemir,et al.  Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. , 2005, American journal of ophthalmology.

[5]  T. Cox,et al.  Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. , 2002, Archives of ophthalmology.

[6]  P. Keane,et al.  Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. , 2008, Ophthalmology.

[7]  L. Labree,et al.  Errors in retinal thickness measurements obtained by optical coherence tomography. , 2006, Ophthalmology.

[8]  J. Català Mora,et al.  Photodynamic Therapy Of Subfoveal Choroidal Neovascularization With Verteporfin. Fluorescein angiographic guidelines for evaluation and treatment-TAP and VIP report nº2 , 2003 .

[9]  P. Kertes,et al.  POTENTIAL PUBLIC HEALTH IMPACT OF AGE-RELATED EYE DISEASE STUDY RESULTS: AREDS REPORT NO. 11 , 2004 .

[10]  Irene Barbazetto,et al.  Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. , 2003, Archives of ophthalmology.

[11]  P. Keane,et al.  Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.

[12]  S. Kishi,et al.  Tomographic findings of foveal hard exudates in diabetic macular edema. , 2001, American journal of ophthalmology.

[13]  A. Tsujikawa,et al.  Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion , 2007, British Journal of Ophthalmology.

[14]  M. Isola,et al.  “Light” versus “classic” laser treatment for clinically significant diabetic macular oedema , 2005, British Journal of Ophthalmology.

[15]  Paul G. Updike,et al.  Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.

[16]  Intravitreal Triamcinolone for Refractory Diabetic Macular Edema: Two-Year Results of a Double-Masked, Placebo-Controlled, Randomized Clinical TrialGillies MC, Sutter FKP, Simpson JM, et al (Univ of Sydney, Australia) Ophthalmology 113:1533–1538, 2006§ , 2007 .

[17]  P. Keane,et al.  Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis , 2008, British Journal of Ophthalmology.

[18]  M. Humayun,et al.  MORPHOMETRIC ANALYSIS OF THE MACULA IN EYES WITH GEOGRAPHIC ATROPHY DUE TO AGE-RELATED MACULAR DEGENERATION , 2002, Retina.

[19]  Kazuaki Miyamoto,et al.  Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion. , 2008, American journal of ophthalmology.

[20]  William J Feuer,et al.  An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.

[21]  C. Regillo,et al.  Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. , 2008, American journal of ophthalmology.

[22]  Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. , 1991, Archives of ophthalmology.

[23]  A. Erginay,et al.  Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. , 2004 .

[24]  M. Humayun,et al.  MORPHOMETRIC ANALYSIS OF THE MACULA IN EYES WITH DISCIFORM AGE-RELATED MACULAR DEGENERATION , 2002, Retina.

[25]  J. Duker,et al.  Intravitreal triamcinolone for refractory diabetic macular edema. , 2002, Ophthalmology.

[26]  Johanna M Seddon,et al.  Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. , 2003, Archives of ophthalmology.

[27]  U Chakravarthy,et al.  Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation , 2008, British Journal of Ophthalmology.

[28]  Paul G. Updike,et al.  Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. , 2008, Ophthalmology.

[29]  Ali Erginay,et al.  Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. , 2003, American journal of ophthalmology.

[30]  W. Goebel,et al.  RETINAL THICKNESS IN DIABETIC RETINOPATHY: A Study Using Optical Coherence Tomography (OCT) , 2002, Retina.

[31]  B. Sander,et al.  Subthreshold micropulse diode laser treatment in diabetic macular oedema , 2004, British Journal of Ophthalmology.

[32]  Ziqiang Wu,et al.  Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. , 2007, Investigative ophthalmology & visual science.

[33]  Susan Schneider,et al.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[34]  Jennifer I. Lim,et al.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. , 2007, Ophthalmology.

[35]  Eric A. Swanson,et al.  Quantitative Assessment of Macular Edema With Optical Coherence Tomography , 1995 .

[36]  W. Freeman,et al.  Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts. , 2008, Ophthalmology.